logo-loader
NASDAQ:BLRX

Bioline RX Ltd

Receive alerts
Market:
NASDAQ
Price
1.15 USD
Day Change
2.68%
Market Cap:
$5.72 m
52 weeks high
3.95
52 weeks low
1.08

In brief

BioLineRx is a clinical-stage, publicly-traded, (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company's declared aim is to develop products suitable for today's pharmaceutical market satisfying an unmet medical need or exhibiting features and benefits above those of current therapies.